Clinical trial
Developing Objective Measures of Levodopa Induced Dyskinesia: (Study 1)
NCT00467597 · US Department of Veterans Affairs, U.S. Fed · Completed
Key facts
| NCT number | NCT00467597 |
|---|---|
| Title | Developing Objective Measures of Levodopa Induced Dyskinesia: (Study 1) |
| Official title | Quantification of Levodopa Induced Dyskinesia in Parkinson Disease: Developing Objective Measures of Levodopa Induced Dyskinesia (Study One) |
| Lead sponsor | US Department of Veterans Affairs, U.S. Fed |
| Collaborators | Oregon Health and Science University |
| Status | Completed |
| Study type | Observational |
| Conditions | Dyskinesias, Movement Disorders, Parkinson Disease |
| Intervention type | Drug |
| Interventions | Levodopa (delivered intravenously) |
| Enrollment | 36 |
| Start date | Apr 1, 2006 |
| Primary completion | Aug 1, 2008 |
| Completion | Oct 1, 2013 |
| First posted | Apr 30, 2007 |
| Last update posted | Nov 26, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: